These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3787832)

  • 1. [Reduced plasminogen activator activity in patients with inactive ulcerative colitis].
    Rask H; Mortensen JZ
    Ugeskr Laeger; 1986 Nov; 148(45):2915-6. PubMed ID: 3787832
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
    Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
    Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
    Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
    Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis].
    Rojas G; Siegel F; Jorquera J; Ardiles L; Valderrama G; Mezzano S
    Rev Med Chil; 1996 Apr; 124(4):449-55. PubMed ID: 9110485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis].
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Ugeskr Laeger; 1983 Jul; 145(30):2302-3. PubMed ID: 6685363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis associated with active ulcerative colitis: percutaneous transhepatic recanalization.
    Miyazaki Y; Shinomura Y; Kitamura S; Hiraoka S; Tomoda K; Nezu R; Kamiike W; Nakamura H; Matsuzawa Y
    Am J Gastroenterol; 1995 Sep; 90(9):1533-4. PubMed ID: 7661189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N
    Hepatogastroenterology; 2007; 54(77):1417-21. PubMed ID: 17708267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the vascular plasminogen activator from the pig ear.
    Klöcking HP; Astedt B; Gerlach D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):851-61. PubMed ID: 6083962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative colitis: why is the mortality from cardiovascular disease reduced?
    Gyde SN; Prior P; Alexander F; Evans S; Taylor K; John WG; Waterhouse JA; Allan RN
    Q J Med; 1984; 53(211):351-7. PubMed ID: 6484117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].
    Tymiński W; Czestochowska E; Swiecicki P
    Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection.
    Chang LC; Meyerhoff ME; Yang VC
    Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stability of tissue plasminogen activator].
    Liutova LV; Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1985; 31(1):97-9. PubMed ID: 3920826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identity of kininogenase and plasminogen activators in human granulocytes].
    Ogloblina OG; Platonova LV; Paskhina TS; Martynov VF; Sorochinskaia EI
    Biokhimiia; 1984 Feb; 49(2):302-9. PubMed ID: 6424731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.